HGF and hepatocellular carcinoma: For example, aberrant NRF2 activation has been identified to accelerate the development of hepatocellular carcinoma (HCC) from pre-cancerous lesions (61) and the HGF/c-Met axis is fundamentally involved in HCC pathogenesis via canonical and non-canonical pathways (62).